Agile Therapeutics, Inc. - Common Stock (NQ:AGRX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agile Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022

October 26, 2022

Live Conference Call and Webcast at 4:30 p.m. ET

From Agile Therapeutics, Inc.

Via GlobeNewswire

Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?

October 26, 2022

From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,...

Via TheNewswire.com

Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?

October 26, 2022

By Ernest Dela Aglanu, Benzinga

Via News Direct

Can This Company's Birth Control Patch Disrupt The Contraceptive Market? ↗

October 25, 2022

Via Benzinga

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

October 21, 2022

Matt Riley - Head of Investor Relations & Corporate Communications

Via TheNewswire.com

Woman-Health Focused Stock Agile Therapeutics Is 'Better Positioned,' Analyst Says While Upgrading Stock ↗

July 26, 2022

Via Benzinga

Agile Therapeutics Tightens Q2 Forecast For Contraceptive Patch 'Twirla' ↗

July 12, 2022

Via Benzinga

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

October 21, 2022

Benzinga Digital Content Studio

Via News Direct

Agile Therapeutics Announces Reorganization of Leadership Team

October 07, 2022

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022

July 28, 2022

Live Conference Call and Webcast at 4:30 p.m. ET

From Agile Therapeutics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022 ↗

July 26, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 26, 2022

Via Benzinga

HC Wainwright Sees Agile Therapeutics' Twirla Tailwinds Post Roe-Wade Ruling ↗

July 12, 2022

Agile Therapeutics Inc's (NASDAQ: AGRX) Twirla, the only low-dose transdermal hormonal contraceptive, should have tailwinds protected after the Supreme Court overturned Roe vs. Wade ruling that...

Via Benzinga

President Biden Mulls Health Emergency For Abortion Access: Report ↗

July 11, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 06, 2022

Gainers

Via Benzinga

How Does The Abortion Ban Affect Birth Control Stocks? ↗

July 05, 2022

The debate over abortion reignited in the US following the Supreme Court’s decision to overturn the landmark 1973 Roe v. Wade ruling that generally protects women’s rights to abortion.

Via Benzinga

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗

July 05, 2022

Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.

Via Benzinga

U.S Stocks Turn Lower; Dow Tumbles Over 100 Points ↗

July 01, 2022

U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Friday.

Via Benzinga

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.

Via Benzinga

Akebia Therapeutics And 20 Stocks Moving Premarket ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday.

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Aspen Aerogels And 28 Stocks Moving Premarket ↗

June 30, 2022

Gainers

Via Benzinga

Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session ↗

June 30, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 29, 2022

Gainers

Via Benzinga

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗

June 30, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

Dow Jumps 150 Points; Icosavax Shares Plunge ↗

June 29, 2022

U.S. stocks turned higher toward the end of trading, with the Dow Jones gaining around 150 points on Wednesday.

Via Benzinga

U.S. Stocks Turn Negative; 2U Shares Spike Higher ↗

June 29, 2022

U.S. stocks pared gains midway through trading, with all the three major indices turning lower on Wednesday.

Via Benzinga

Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session ↗

June 29, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

Why U.S. Stocks Are Trading Higher, GDP Report And More ↗

June 29, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 180 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 29, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.